Form 13-F position report

ONCONOVA THERAPEUTICS INC

Reported by SABBY MANAGEMENT LLC

ONTXW CUSIP 68232V116 Manager CIK 0001535610

Reported 0 shares, down 631,812 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2019
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 14 Through Q4 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for ONCONOVA THERAPEUTICS INC held by SABBY MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

6 managers reported ONCONOVA THERAPEUTICS INC for Q4 2019.

Managers reporting ONCONOVA THERAPEUTICS INC in Q4 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
TYNDALL CAPITAL PARTNERS L P Unchanged 390,624 0 0.6% $14,000 14 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 42,467 -46,154 < 0.01% $2,000 4 qtrs
UBS Group AG Reduced 0 -3,784 0 $0 9 qtrs
SABBY MANAGEMENT LLC This report Reduced 0 -631,812 0 $0 14 qtrs
CVI Holdings LLC Reduced 0 -132,227 0 $0 8 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2019
Filed
February 14, 2020
Filing type
13F-HR
Position type
*W

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.